• Study of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Hungary Italy Poland Romania +1
  • Safety Study of Regulatory T Cells (Treg02) and Tacrolimus Discontinuation in Adult Liver Transplant Recipients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    2 1 1 1
    Investigated diseases:
    Norway Sweden
  • Study of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement

    Recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

    Recruiting

    3 1 1
    Investigated diseases:
    Bulgaria Hungary Latvia Lithuania Poland Romania
  • Study of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation

    Recruiting

    3 1 1
    Investigated drugs:
    France
  • Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren’s disease

    Recruiting

    2 1 1 1
    Bulgaria France Germany Italy Poland Portugal +2
  • Study of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan

    Recruiting

    2 1
    Czechia Hungary Italy Poland Romania Spain +1
  • Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

    Recruiting

    2 1
    Investigated diseases:
    Bulgaria Denmark Germany Greece Hungary Italy +2
  • Study of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland

powered by